ACC.24 Late-breaking Science Preview
View from the Thoraxcenter: ACC.24 Late-breaking Science Preview

Average (ratings)
No ratings
 
  Your rating

What’s hot at ACC.24?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.

This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24, highlighting their context and relevance for practice.

Trials covered include:
0:42 - IVUS-ACS: Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes
2:22 - Ultimate DAPT: One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes
4:02 - RELIEVE-HF: A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients With HFrEF and HFpEF
6:52 - ORBITA-COSMIC: Coronary Sinus Reducer for the Treatment of Refractory Angina
8:52 -  EMPACT-MI: Empagliflozin After Acute Myocardial Infarction
10:15 - REDUCE-AMI: Long-term Beta-blocker Treatment After Acute Myocardial Infarction and Preserved Left Ventricular Ejection Fraction
12:39 - SMART: Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli
14:44 - DEDICATE-DZHK6: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients at Low to Intermediate Risk
16:56 - PERFORM-TAVR: Protein and Exercise to Reverse Frailty in Older Men and Women Undergoing Transcatheter Aortic Valve Replacement
18:13 - PREVENT: Preventive PCI or Medical Therapy Alone for Atherosclerotic Coronary Vulnerable Plaques
21:32 - FULL REVASC: Ffr-guidance for complete non-culprit REVASCularization
22:46 - DanGer Shock: Danish-German cardiogenic shock trial
25:18 - TARGET BP I: Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs


Read MoreRead Less
Also listen on
Share
Also listen on
Up Next
View from the Thoraxcenter: ACC.24 Wrap Up
EP32 • Apr 15, 2024 • 43m 48s
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.
Read More
All Episodes
Ep 3: Atrial Fibrillation in Congenital Heart Disease
EP3 • Nov 30, 2021 • 16m 52s
Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?

Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Read More
Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI
EP02 • Oct 29, 2021 • 20m 38s
Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?

Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
Read More
Ep 1: Women and Heart Disease
EP1 • Oct 01, 2021 • 44m 44s
Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men? Dr Erin Michos (John Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in the latest special focus issue in the European cardiology Review journal.
Read More
Ep 9: Sex Differences in Hypertension: Pharmacological Treatment
EP18 • Oct 31, 2022 • 25m 38s
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations. 
Read More
Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention
EP17 • Sep 30, 2022 • 23m 47s
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?

In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention
EP16 • Sep 12, 2022 • 26m 25s
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk
EP15 • Jun 29, 2022 • 28m 46s
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data
EP14 • May 16, 2022 • 7m 25s
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More